Laminopathies Amyotrophic lateral sclerosis LMNA Regeneration AAV Duchenne muscular dystrophy Lamin A/C Rare neuromuscular diseases Cell therapy Satellite cell PABPN1 Glutamate Congenital myopathy Centronuclear myopathy Dermatomyositis LMNA gene Dynamin 2 Myasthenia gravis Myoblasts Muscle regeneration Long read sequencing Myopathy Animals Treatment Cardiomyopathy CMS Biomarker Autoimmune diseases Neuromuscular junction Heart failure Dystrophin Myopathies Mechanotransduction Neuromuscular diseases CRISPRi Actin Diagnosis Skeletal muscle RNA interference Therapy Becker muscular dystrophy Genotype phenotype correlation Exercise Errance diagnostique Antisense oligonucleotides Outcome measures Calcium FSHD Alternative splicing Humans DMD RNA biology Transcriptomics Heart ALS Inflammation Laminopathy Myasthenia Gravis MG Transgenic mouse model Cytokines Myotonic dystrophy type 1 Dilated cardiomyopathy Myogenesis Trinucleotide repeat expansion Thymus Cancer Laminopathie Mouse model Neuromuscular disease Astrocyte Myositis Brain Biomarkers Cytoskeleton CTG repeat contractions Thérapie génique COVID-19 Aged Lamin A/C LMNA gene MBNL Myotonic Dystrophy type 1 Autoantibodies Fibrosis Myotonic dystrophy Aging Muscle Clinical trials Rare diseases OPMD Myotonic Dystrophy Gene therapy Satellite cells Fabry disease Autophagy Congenital muscular dystrophy Autoimmunity Male Nuclear envelope Motoneuron Muscular dystrophy